- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01195844
Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).
February 23, 2015 updated by: Merck Sharp & Dohme LLC
Rotavirus Gastroenteritis in Children Up to 5 Years of Age. Surveillance Performed in Hospitals From Four Brazilian Regions.
This is a 1-year study evaluating hospitalizations and the medical care for the treatment of diarrhea from rotavirus infection in children < 5 years of age, conducted in four hospitals located in four Brazilian regions.
A stool sample from each eligible child passing 3 or more loose stools or watery stools within a period of 24 hours and requiring hospitalization or rehydration therapy (oral or IV rehydration) will be tested for the presence of rotavirus, using standard laboratory procedures (ie, Enzyme Linked Ligand Sorbent Assay, or ELlSA) by all participating hospitals.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
230
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children less than 5 years of age from four Brazilian cities with diarrhea attributed to rotavirus infection.
Description
Inclusion Criteria:
- a child < 5 years of age being treated for acute gastroenteritis within 72 hours prior to evaluation in the study hospitals.
- outpatient children < 5 years of age submitted for treatment of acute gastroenteritis within 72 hours prior to evaluation in the study clinics.
Exclusion Criteria:
- none specified
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Brazilian Children With Rotavirus Gastroenteritis
Brazilian children under 5 years of age who have diarrhea attributed to rotavirus located in 4 hospitals from 4 different Brazilian regions
|
This is an observational study evaluating hospitalizations and the medical care for the treatment of diarrhea from rotavirus infection in children < 5 years of age; however, any rotavirus vaccines used in the children presenting with rotavirus-attributed diarrhea were evaluated, as well the prevalent rotavirus serotypes in this sample for future vaccine development.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Number of Hospitalizations for Diarrhea in Children up to 5 Years of Age
Time Frame: 1 year
|
The total number of hospitalizations for diarrhea in children up to 5 years of age in the 4 Brazilian hospital research centers was reported.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
|
1 year
|
|
The Percentage of Hospitalizations for Diarrhea in Children up to 5 Years of Age
Time Frame: 1 year
|
The percentage of total hospitalizations for children up to 5 years of age in the 4 Brazilian hospital research centers that were for diarrhea.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
|
1 year
|
|
The Geographic Distribution of Hospitalizations for Diarrhea That Are Caused by Rotavirus
Time Frame: 1 year
|
Children up to 5 years of age hospitalized for diarrhea were tested for fecal rotavirus as determined by enzyme immunoassay.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
For each geographic location, the number of hospitalizations for diarrhea that was caused by rotavirus was reported.
|
1 year
|
|
The Percentage of Hospitalizations for Diarrhea That Are Caused by Rotavirus
Time Frame: 1 year
|
Children up to 5 years of age hospitalized for diarrhea were tested for fecal rotavirus as determined by enzyme immunoassay.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
The number of hospitalizations for diarrhea from rotavirus infection was divided by the total number of hospitalizations for diarrhea in the 4 hospital research centers.
|
1 year
|
|
The Number of Hospitalizations for Diarrhea That Are Caused by Rotavirus by Age Group
Time Frame: 1 year
|
Children up to 5 years of age hospitalized for diarrhea were tested for fecal rotavirus as determined by enzyme immunoassay.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
The number of hospitalizations for diarrhea from rotavirus infection was reported for each age group.
|
1 year
|
|
The Numbers of Participants Hospitalized for Diarrhea and Rotavirus-caused Diarrhea Per Month
Time Frame: 1 year
|
Children up to 5 years of age hospitalized for diarrhea were tested for fecal rotavirus as determined by enzyme immunoassay.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
|
1 year
|
|
The Duration of Hospitalization for Participants Enrolled in the Study
Time Frame: From hospital admission to discharge
|
The mean duration (days) of hospital stay for children up to 5 years of age hospitalized for diarrhea in the 4 Brazilian hospital research centers.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
|
From hospital admission to discharge
|
|
The Number of Deaths in Hospitalized Participants Enrolled in the Study
Time Frame: 1 year
|
The number of deaths among children up to 5 years of age hospitalized for diarrhea in the 4 Brazilian hospital research centers.
Diarrhea was defined as the passage of 3 or more soft/liquid feces in a 24-hour period.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Divina das Dores P Cardoso, Doctor, Instituto de Patologia Tropical e Saúde Pública IPTSP-UFG
- Principal Investigator: Edson Moreira, MD, PhD, Hospital Santo Antonio - Obras Sociais Irma Dulce
- Principal Investigator: Alfredo Gilio, MD, Hospital Universitário da Universidade de Sao Paulo
- Principal Investigator: Paulo Carvalho, MD, Hospital de Clínicas da Universidade Federal do Rio de Grande do Sul
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
September 3, 2010
First Submitted That Met QC Criteria
September 3, 2010
First Posted (Estimate)
September 6, 2010
Study Record Updates
Last Update Posted (Estimate)
March 12, 2015
Last Update Submitted That Met QC Criteria
February 23, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- V260-031
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Gastroenteritis
-
University of AlbertaStollery Children's HospitalCompletedPediatric ALL | Acute Gastroenteritis | Knowledge TranslationCanada
-
University of North Carolina, Chapel HillPatient-Centered Outcomes Research Institute; Duke Clinical Research InstituteRecruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis, PediatricUnited States
-
Kelly BooneChildren's Hospital Medical Center, CincinnatiTerminatedInflammatory Bowel Diseases | Pediatric Ulcerative Colitis | Pediatric Crohns DiseaseUnited States
-
Tanabe Pharma CorporationCompleted
-
Hôpital Necker-Enfants MaladesInstitut National de la Santé Et de la Recherche Médicale, France; NestléUnknownCrohn's Disease | PediatricFrance
-
Rhode Island HospitalEnrolling by invitationGastrointestinal Diseases | Colitis | Pediatric Disorder | Pediatric Crohns Disease | Procedural SequelaeUnited States
-
Hospices Civils de LyonNot yet recruitingCrohn Disease | Pediatric Crohns DiseaseFrance
-
University of North Carolina, Chapel HillUniversity of Amsterdam; Crohn's and Colitis Foundation; OM Pharma SATerminatedCrohn Disease | Pediatric Crohns DiseaseUnited States, Netherlands, Canada, Israel
-
Children's Hospital Los AngelesCompleted
-
Azienda Policlinico Umberto ICompletedPediatric | Colon Capsule EndoscopyItaly
Clinical Trials on Rotavirus Vaccine
-
Butantan InstituteCompleted
-
Federico II UniversityMerck Sharp & Dohme LLCNot yet recruitingMeningococcal Infections | Rotavirus Infections | Vaccination
-
Centre for Infectious Disease Research in ZambiaImperial College London; Christian Medical College, Vellore, IndiaCompletedDiarrhoeal DiseaseZambia
-
GlaxoSmithKlineCompletedInfections, RotavirusFinland, Germany, Spain, Italy, France, Czech Republic
-
GlaxoSmithKlineCompletedRotavirus InfectionsSouth Africa
-
Serum Institute of India Pvt. Ltd.Completed
-
GlaxoSmithKlineCompletedInfections, RotavirusVietnam
-
GlaxoSmithKlineCompleted
-
International Centre for Diarrhoeal Disease Research...PATHCompletedRotavirus GastroenteritisBangladesh